SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
McDonald Scott

(Last) (First) (Middle)
1166 AVENUE OF THE AMERICAS

(Street)
NEW YORK NY 10036

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
01/01/2014
3. Issuer Name and Ticker or Trading Symbol
MARSH & MCLENNAN COMPANIES, INC. [ MMC ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
CEO of Oliver Wyman Group
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 7,480.061 D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units (1) (1) Common Stock 22,191 (2) D
Stock Options (Right to Buy) (3) 03/15/2015 Common Stock 9,000 $30.505 D
Stock Options (Right to Buy) (4) 03/14/2016 Common Stock 3,500 $30.215 D
Stock Options (Right to Buy) (5) 02/11/2017 Common Stock 1,576 $29.6 D
Stock Options (Right to Buy) (6) 02/25/2018 Common Stock 2,023 $26.07 D
Stock Options (Right to Buy) (7) 02/21/2020 Common Stock 11,200 $22.705 D
Stock Options (Right to Buy) (7) 02/21/2020 Common Stock 218 $22.705 D
Stock Options (Right to Buy) (8) 02/20/2021 Common Stock 11,245 $30.595 D
Stock Options (Right to Buy) (9) 02/23/2022 Common Stock 13,039 $31.885 D
Stock Options (Right to Buy) (10) 02/24/2023 Common Stock 20,162 $36.495 D
Explanation of Responses:
1. Not Applicable.
2. The security converts to Marsh & McLennan Companies common stock on a 1-for-1 basis.
3. These options vested in four equal annual installments on March 16th of 2006, 2007, 2008, and 2009. These options became exercisable when, after they vested, the closing price of Marsh & McLennan Companies common stock was at least 15% higher than the exercise price of the options for ten consecutive trading days.
4. These options vested in four equal annual installments on March 15th of 2007, 2008, 2009, and 2010. These options became exercisable when, after they vested, the closing price of Marsh & McLennan Companies common stock was at least 15% higher than the exercise price of the options for ten consecutive trading days.
5. These options vested in four equal annual installments on February 12th of 2008, 2009, 2010, and 2011. These options became exercisable when, after they vested, the closing price of Marsh & McLennan Companies common stock was at least 15% higher than the exercise price of the options for ten consecutive trading days.
6. These options vested in four equal installments and became exercisable on February 26th of 2009, 2010, 2011, and 2012.
7. These options were granted on February 22, 2010 and vest in four equal annual installments beginning on the first anniversary of the grant date. The first three installments vested and became exercisable on February 22nd of 2011, 2012, and 2013. The remaining installment vests on February 22, 2014.
8. These options were granted on February 21, 2011 and vest in four equal annual installments beginning on the first anniversary of the grant date. The first two installments vested and became exercisable on February 21st of 2012, and 2013. The remaining installments vest on February 21st of 2014, and 2015.
9. These options were granted on February 24, 2012 and vest in four equal annual installments beginning on the first anniversary of the grant date. The first installment vested and became exercisable on February 24, 2013. The remaining installments vest on February 24th of 2014, 2015, and 2016.
10. These options were granted on February 25, 2013 and vest in four equal annual installments on February 25th of 2014, 2015, 2016, and 2017.
/s/ Lucy Fato, Attorney-in-Fact 01/06/2014
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.